WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4201 Infant (under 12 months) mortality rate: 362
GDP / capita (US$): 1'4591 Child (under 5 years) mortality rate: 502

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 24'895  24'234  23'590  22'961  22'347  15'767  11'599  8'717 
Births 827  812  796  782  769  651  516  403 
Surviving infants 801  785  769  754  740  608  462  357 
Pop. less than 5 years 3'769  3'700  3'635  3'580  3'528  2'842  2'092  1'635 
Pop. less than 15 years 10'280  10'092  9'914  9'742  9'572  7'119  5'285  4'024 
Female 15-49 years 6'067  5'877  5'689  5'505  5'324  3'643  2'617  1'915 

Number of reported cases

(Click for retrospective incidence data for Madagascar)
Diphtheria
ChartChart
  2'865  1'627  12  252  227 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  35'256  14'459  119'679 
Mumps
ChartChart
 
Pertussis
ChartChart
  321  413  19  33  3'880  1'333  32'457 
Polio*
ChartChart
  10  39  68 
Rubella
ChartChart
  204  89  162  131  110 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  27  13  13  208 
Tetanus (total)**
ChartChart
  136  200  131  556  490  54  208  842 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Madagascar)
Vaccine year result method % card seen                                                
BCG 2011  74     46  92  70  75  77  78  99*  98  21 
DTP1 2011  80     46  99*  95  99  96  97  86 
DTP3 2011  63     46  93  85  89  90  86  80  71  48 
DTP4         
IPV1          65  30 
HepB_BD         
HepB3 2011  63     46  93  85  89  90  86 
Hib3 2011  63     46  93  85  89  90  86 
JapEnc         
MCV1          97  81  87  86  85  81  57 
MCV2         
MenA         
PCV1          99*  93  96  95  65 
PCV2          93  87  89  93  15 
PCV3          92  85  88  92 
Pol3 2011  63     46  90  86  88  88  86  81  69 
Rota1          96  87  67 
RotaC          89  80  50 
RCV1         
TT2plus          52  47  53  63  59  40  31 
PAB          67  60  67 
VAD1          63  94 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Madagascar)
BCG
ChartChart
  70  70  75  77  78  72  67  21 
DTP1
ChartChart
  84  79  83  80  80  74  71 
DTP3
ChartChart
  77  69  73  74  70  57  46 
HepB3
ChartChart
  77  69  73  74  70 
HepB_BD
 
Hib3
ChartChart
  77  69  73  74  70 
IPV1
  65  30 
MCV1
ChartChart
  58  58  64  63  61  57  47 
MCV2
 
PCV3
ChartChart
  76  69  72  76 
Pol3
ChartChart
  75  71  73  73  71  58  46 
RCV1
 
RotaC
ChartChart
  78  69  39 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 113  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 63
From 80 to 89% 31
From 50 to 79% 5
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; 6 months; No
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitA 6-12 months; 12-59 months; Yes
VitaminA 6 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2019  2016-2019  2013-2016  2010-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 113  112  112  112  112  112  111 

System performance

Total Nº districts in country number 113  112  112  112  112  112  111 
Nº districts with DTP3 coverage >=80% number 106  74  90  85  76  86  65 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  66  80  76  68  77  59 
Nº districts with measles (MCV1) coverage >=95% number 60  18  39  34  25  21  41 
% of districts with MCV1 coverage >=95% From 0 to 100% 53  16  35  30  22  19  37 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 36    23 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  Yes  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.